ST. LOUIS, MO. og GENEVE, SCHWEIZ — 7. august 2024 — Unilabs ("Unilabs"), en førende international udbyder af diagnostiske tjenester, og C2N Diagnostics, LLC ("C2N"), en pioner inden for avancerede diagnostiske løsninger inden for Alzheimers sygdom (AD) og relaterede neurologiske sygdomme, annoncerede i dag en vigtig milepæl inden for diagnosticering og forskning af hjernens sundhed i Europa og videre.
Given the fast growing size of the company and the increasing number of countries where it operates, Unilabs has resized the management structure into a smaller Unilabs Management Team (UMT), effective from 1st January 2018.
Unilabs is pleased to announce the acquisition of Telemedicine Clinic (“TMC”), a leading European provider of teleradiology and telepathology services.
Unilabs SubHolding AB (publ) today announced that it has priced its offering of €155 million aggregate principal amount of its existing 5.75% senior notes due 2025 (the “Notes”).
Unilabs SubHolding AB (publ) (the “Issuer”) today announced the offering of €130,000,000 aggregate principal amount of its existing 5.75% senior notes due 2025 (the “Notes”).
Unilabs, Europe’s leading provider of clinical laboratory testing and medical diagnostic imaging services, reports a solid Q2 2017, delivering the 12th consecutive quarter of EBITDA growth.
Unilabs today announced it has signed a definitive agreement to acquire a share of Scientific Clinical Laboratories (SCL) for an undisclosed amount. Established in 1990, SCL has been providing highly-specialised laboratory services in the UAE, with a strong brand recognition and a leading market position.